{{unreferenced|date=October 2012}}
{{Drugbox
| IUPAC_name        = (1''R'',2''R'',3''S'',4''R'',6''S'')-4,6-Diamino-3-hydroxy-2-<nowiki/>{[α-<small>D</small>-mannopyranosyl-(1->4)-2,6-diamino-2,6-dideoxy-β-<small>L</small>-idopyranosyl-(1->3)-β-<small>D</small>-ribofuranosyl]oxy}cyclohexyl 2-amino-2,3-dideoxy-α-<small>D</small>-ribo-hexopyranoside
| image             = Lividomycin.svg
| CAS_number        = 36441-41-5
| ATC_prefix        = 
| ATC_suffix        = 
| PubChem           = 72394
| DrugBank          = DB04728
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 71961
| ChEMBL = 389029
| ChemSpiderID      = 65327
| C=29 | H=55 | N=5 |O=19
| molecular_weight = 777.769 g/mol
| smiles            = O([C@H]4[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@H]2O[C@@H](CN)[C@@H](O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)[C@H](O)[C@H]2N)[C@H]3O)[C@@H](O)[C@H](N)C[C@@H]4N)[C@H]5O[C@@H]([C@@H](O)C[C@H]5N)CO
| StdInChI          = 1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1
| StdInChIKey       = DBLVDAUGBTYDFR-SWMBIRFSSA-N
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 
| pregnancy_AU      =  <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      =  <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU =  <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA =  <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK =  <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US =  <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = 
}}

'''Lividomycin''' is an [[aminoglycoside]] [[antibiotic]].

[[Category:Aminoglycoside antibiotics]]


{{antibiotic-stub}}